Literature DB >> 4151694

Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.

D G Shand.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4151694     DOI: 10.2165/00003495-197407010-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  29 in total

1.  Metabolic studies on oxprenolol in animals and man by means of radio-tracer techniques and GLC-analysis.

Authors:  W Riess; T G Rajagopalan; P Imhof; K Schmid; H Keberle
Journal:  Postgrad Med J       Date:  1970-11       Impact factor: 2.401

2.  The effect of chronic adrenergic receptor blockade on plasma renin activity in man.

Authors:  A M Michelakis; R G McAllister
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

3.  Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

Authors:  G H Evans; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

4.  Relation of propranolol plasma level to beta-blockade during oral therapy.

Authors:  R Zacest; J Koch-Weser
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

5.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

6.  Multicenter trial of propranolol in angina pectoris.

Authors:  R H Grant; P Keelan; R J Kernohan; J C Leonard; L Nancekievill; K Sinclair
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

7.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

8.  Relative potency of intravenous prinodolol and propranolol in man.

Authors:  A G Arbab; D C Hicks; P Turner
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

9.  Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.

Authors:  J D Fitzgerald; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

10.  Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man.

Authors:  R C Hill; P Turner
Journal:  Br J Pharmacol       Date:  1969-06       Impact factor: 8.739

View more
  45 in total

1.  Effects of beta-adrenoreceptor blocking drugs on adrenergic transmission.

Authors:  M Rand; M Law; D F Story; M W McCulloch
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 2.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

3.  Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.

Authors:  J M Bell; C J Russell; J K Nelson; J G Kelly; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

Review 4.  Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.

Authors:  William H Frishman; Mamata Alwarshetty
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Pharmacokinetic optimisation of therapy with beta-adrenergic blocking agents.

Authors:  W H Frishman; E J Lazar; G Gorodokin
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

Review 6.  Pharmacologic considerations in the positioning of beta-blockers in antihypertensive therapy.

Authors:  Domenic A Sica; Henry R Black
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

7.  Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

Authors:  H C Brown; S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

8.  Current status of Beta blocker therapy.

Authors:  J D Gray
Journal:  Can Fam Physician       Date:  1980-05       Impact factor: 3.275

Review 9.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

10.  Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.

Authors:  J D Fitzgerald; R Ruffin; K G Smedstad; R Roberts; J McAinsh
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.